About: Neurological comorbidity and severity of COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neurological comorbidity and severity of COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Neurological comorbidity and severity of COVID-19
Creator	Artusi, Alberto Balestrino, Roberta Bozzali, · Carlo, · Ciccone, Giovannino Ferrero, Bruno Imbalzano, Gabriele Lopiano, Leonardo Mario, · Montalenti, Elisa Montanaro, Elisa Riccardini, · Rizzone, Giorgio Romagnolo, Alberto Vaula, Giovanna Zibetti, Maurizio
Source	Medline; PMC
abstract	OBJECTIVE: Neurological symptoms of COVID-19 patients have been recently described. However, no comprehensive data have been reported on pre-existing neurological comorbidities and COVID-19. This study aims at evaluating the prevalence of neurological comorbidities, and their association with COVID-19 severity. METHODS: We evaluated all consecutive patients admitted to the Emergency Room (ER) of our hospital between the 3rd March and the 14th April 2020, and diagnosed with COVID-19. Data on neurological and non-neurological diseases were extracted, as well as data on demographic characteristics and on severity degree of COVID-19. The prevalence of neurological comorbidities was calculated, and multivariate binary logistic regression analyses were used to estimate the association between neurological diseases and COVID-19 severity. RESULTS: We included 344 patients. Neurological comorbidities accounted for 22.4% of cases, with cerebrovascular diseases and cognitive impairment being the most frequent. Neurological comorbidity resulted independently associated with severe COVID-19 (OR 2.305; p = 0.012), as well as male gender (p = 0.001), older age (p = 0.001), neoplastic diseases (p = 0.039), and arterial hypertension (p = 0.045). When neurological comorbidity was associated with non-neurological comorbidities, the OR for severe COVID-19 rose to 7.394 (p = 0.005). Neurological patients, in particular cerebrovascular and cognitively impaired ones, received more respiratory support indication. CONCLUSION: Neurological comorbidities represent a significant determinant of COVID-19 severity, deserving a thorough evaluation since the earliest phases of infection. The vulnerability of patients affected by neurological diseases should suggest a greater attention in targeting this population for proactive viral screening.
has issue date	2020-08-04(xsd:dateTime)
bibo:doi	10.1007/s00415-020-10123-y
bibo:pmid	32749601
has license	cc-by
sha1sum (hex)	53a5c55049c00a60096f039f7f1e85ca2fcf2831
schema:url	https://doi.org/10.1007/s00415-020-10123-y
resource representing a document's title	Neurological comorbidity and severity of COVID-19
has PubMed Central identifier	PMC7400751
has PubMed identifier	32749601
schema:publication	J Neurol
resource representing a document's body	covid:53a5c55049c00a60096f039f7f1e85ca2fcf2831#body_text
is schema:about of	named entity 'neurological' named entity 'screening' named entity 'Neurological' named entity 'support' named entity 'COVID-19' named entity 'comorbidities' named entity 'Neurological' named entity 'COVID-19' named entity 'neurological' named entity 'Data' named entity 'Neurological' named entity 'REPORTED' named entity 'RESULTS' named entity 'CEREBROVASCULAR DISEASES' named entity 'BEING' named entity '28P' named entity 'INFECTION' named entity 'GREATER' named entity 'NON-' named entity 'LOGISTIC REGRESSION' named entity 'HOSPITAL' named entity 'COMORBIDITY' named entity 'SIGNIFICANT' named entity 'COGNITIVE IMPAIRMENT' named entity 'CALCULATED' named entity 'REPRESENT' named entity 'PARTICULAR' named entity 'COVID-19' named entity 'DATA' named entity 'cases' named entity 'independently' named entity 'Objective' named entity 'COVID-19' named entity 'neurological' named entity 'arterial hypertension' named entity 'neurological diseases' named entity 'symptoms' named entity 'evaluated' named entity 'determinant' named entity 'This' named entity 'comorbidities' named entity 'severe' named entity 'cognitively impaired' named entity 'Neurological' named entity 'demographic characteristics' named entity 'COVID-19' named entity 'binary logistic regression' named entity 'neoplastic diseases' named entity 'neurological' named entity 'Emergency Room' named entity 'COVID-19' named entity 'Neurological' named entity 'Neurological' named entity 'COVID-19' named entity 'comorbidity' named entity 'neurological diseases' named entity 'COVID' named entity 'health surveillance' named entity 'hypertension' named entity 'neurological diseases' named entity 'comorbidity' named entity 'SARS-CoV' named entity 'peripheral neuropathy' named entity 'neurological condition' named entity 'risk factor' named entity 'neurological diseases'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software